A5062725136- Chronic Myeloid Leukemia Treatments
- Eosinophilic Disorders and Syndromes
- Chronic Lymphocytic Leukemia Research
- Circular RNAs in diseases
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- T-cell and Retrovirus Studies
- Electromagnetic wave absorption materials
- RNA Research and Splicing
- Hematological disorders and diagnostics
- RNA modifications and cancer
- Advanced Antenna and Metasurface Technologies
- Acute Myeloid Leukemia Research
- Immune Response and Inflammation
- Aluminum Alloys Composites Properties
Zhejiang University of Technology
2024
Panyu District Central Hospital
2020-2023
A series of urchin-like porous Co/CoO/C composites with wideband and strong EWA performance have been prepared, in which the 3D microstructures facilitate propagation attenuation electromagnetic waves.
Chronic myeloid leukemia (CML) is a chronic disease with treatment-free remission (TFR) increasingly regarded as feasible goal of treatment. However, various factors may influence adherence to international guidelines for CML management. This study aimed compare the reporting care between patients and their treating doctors. Parallel patient physician online surveys were conducted September 22, 2021, March 15, 2022, which focused on perceptions 1882 adult 305 physicians regarding tyrosine...
Abstract Background: This research aimed to explore the genetic association of Toll-like receptor 2 ( TLR2 ) gene polymorphisms with acute myelocytic leukemia (AML) susceptibility in Chinese population. Methods: Firstly, genotypes polymorphism were detected 148 AML patients and 126 healthy controls by polymerase chain reaction (PCR). The genotype distribution every control group was whether conformed Hardy-Weinberg equilibrium (HWE). frequency difference between case groups compared...
The experience of a physician at clinical center is among the critical factors in managing chronic myeloid leukemia (CML) during its treatment with tyrosine kinase inhibitors (TKIs). authors conducted cross-sectional questionnaire to investigate barriers use published evidence-based guidelines CML management real-world setting. Among participating physicians (N = 407), 99.8% reported that were useful; however, only 62.9% they follow real-time. Although 90.7% prefer second-generation TKIs as...
Background: The key circular RNAs (circRNAs) and the molecular mechanisms by which they regulate progression of acute myeloid leukemia (AML) in adults are unclear. Methods: We used a circRNA microarray to analyze differentially expressed circRNAs peripheral blood mononuclear cells newly diagnosed adult AML patients. Reverse transcription-PCR, fluorescence situ hybridization, Sanger sequencing, ribonuclease R tests were examine circRNF220 loop formation stability its potential value...
Abstract Background: The key circular RNAs (circRNAs) and the molecular mechanisms by which they regulate progression of acute myeloid leukemia (AML) in adults are unclear. Methods: We used a circRNA microarray to analyze differentially expressed circRNAs peripheral blood mononuclear cells newly diagnosed adult AML patients. Reverse transcription-PCR, fluorescence situ hybridization, Sanger sequencing, ribonuclease R tests were examine circRNF220 loop formation stability its potential value...